Daniel Karlin insider trades

Open-market stock purchases and sales by Daniel Karlin, Chief Medical Officer at Definium Therapeutics, Inc, from SEC Form 4 filings since Mar 12, 2025.

Recent trades

DateStockTradeValue
Sep 25, 2026DFTX Definium Therapeutics, IncSold$397K
Sep 14, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Aug 12, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Jun 25, 2026DFTX Definium Therapeutics, IncSold$452K
Jun 22, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Mar 25, 2026DFTX Definium Therapeutics, IncSold$148K
Feb 3, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Dec 26, 2025MNMD Mind Medicine (MindMed) IncSold$73.6K

Companies traded

  • DFTX Definium Therapeutics, Inc: 3 sales, last Sep 25, 2026
  • MNMD Mind Medicine (MindMed) Inc: 4 sales, last Dec 26, 2025

Get free alerts when Daniel Karlin files a new trade →